ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nuclear Medicine Radioisotopes Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-26U7204
Home | Market Reports | Health| Medical Devices & Equipment
Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2028
BUY CHAPTERS

Global Nuclear Medicine Radioisotopes Market Research Report 2025

Code: QYRE-Auto-26U7204
Report
August 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare

Nuclear Medicine Radioisotopes Market Size

The global market for Nuclear Medicine Radioisotopes was valued at US$ 3802 million in the year 2024 and is projected to reach a revised size of US$ 4757 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Nuclear Medicine Radioisotopes Market

Nuclear Medicine Radioisotopes Market

Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Radioisotopes.
The Nuclear Medicine Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nuclear Medicine Radioisotopes Market Report

Report Metric Details
Report Name Nuclear Medicine Radioisotopes Market
Accounted market size in year US$ 3802 million
Forecasted market size in 2031 US$ 4757 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Thallium-201 (Tl-201)
  • Iodine (I-123)
  • Fluorine-18
  • Rubidium-82 (Rb-82)
  • Other
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nuclear Medicine Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nuclear Medicine Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Nuclear Medicine Radioisotopes Market growing?

Ans: The Nuclear Medicine Radioisotopes Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Nuclear Medicine Radioisotopes Market size in 2031?

Ans: The Nuclear Medicine Radioisotopes Market size in 2031 will be US$ 4757 million.

Who are the main players in the Nuclear Medicine Radioisotopes Market report?

Ans: The main players in the Nuclear Medicine Radioisotopes Market are Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare

What are the Application segmentation covered in the Nuclear Medicine Radioisotopes Market report?

Ans: The Applications covered in the Nuclear Medicine Radioisotopes Market report are Tumor, Heart Disease, Lymphoma, Thyroid Gland, Other

What are the Type segmentation covered in the Nuclear Medicine Radioisotopes Market report?

Ans: The Types covered in the Nuclear Medicine Radioisotopes Market report are Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Other

Recommended Reports

Nuclear Medicine Markets

Radioisotope & Therapy

Radiology and Oncology

1 Nuclear Medicine Radioisotopes Market Overview
1.1 Product Definition
1.2 Nuclear Medicine Radioisotopes by Type
1.2.1 Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024 VS 2031)
1.2.2 Thallium-201 (Tl-201)
1.2.3 Iodine (I-123)
1.2.4 Fluorine-18
1.2.5 Rubidium-82 (Rb-82)
1.2.6 Other
1.3 Nuclear Medicine Radioisotopes by Application
1.3.1 Global Nuclear Medicine Radioisotopes Market Value by Application (2024 VS 2031)
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Lymphoma
1.3.5 Thyroid Gland
1.3.6 Other
1.4 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
1.4.1 Global Nuclear Medicine Radioisotopes Revenue 2020-2031
1.4.2 Global Nuclear Medicine Radioisotopes Sales 2020-2031
1.4.3 Global Nuclear Medicine Radioisotopes Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nuclear Medicine Radioisotopes Market Competition by Manufacturers
2.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nuclear Medicine Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Product Type & Application
2.7 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Date of Enter into This Industry
2.8 Global Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
2.8.1 Global Nuclear Medicine Radioisotopes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
2.8.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Medicine Radioisotopes Market Scenario by Region
3.1 Global Nuclear Medicine Radioisotopes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nuclear Medicine Radioisotopes Sales by Region: 2020-2031
3.2.1 Global Nuclear Medicine Radioisotopes Sales by Region: 2020-2025
3.2.2 Global Nuclear Medicine Radioisotopes Sales by Region: 2026-2031
3.3 Global Nuclear Medicine Radioisotopes Revenue by Region: 2020-2031
3.3.1 Global Nuclear Medicine Radioisotopes Revenue by Region: 2020-2025
3.3.2 Global Nuclear Medicine Radioisotopes Revenue by Region: 2026-2031
3.4 North America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.4.1 North America Nuclear Medicine Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nuclear Medicine Radioisotopes Sales by Country (2020-2031)
3.4.3 North America Nuclear Medicine Radioisotopes Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.5.1 Europe Nuclear Medicine Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nuclear Medicine Radioisotopes Sales by Country (2020-2031)
3.5.3 Europe Nuclear Medicine Radioisotopes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medicine Radioisotopes Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2020-2031)
3.6.3 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medicine Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nuclear Medicine Radioisotopes Sales by Country (2020-2031)
3.7.3 Latin America Nuclear Medicine Radioisotopes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medicine Radioisotopes Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nuclear Medicine Radioisotopes Sales by Type (2020-2031)
4.1.1 Global Nuclear Medicine Radioisotopes Sales by Type (2020-2025)
4.1.2 Global Nuclear Medicine Radioisotopes Sales by Type (2026-2031)
4.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2031)
4.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2020-2031)
4.2.1 Global Nuclear Medicine Radioisotopes Revenue by Type (2020-2025)
4.2.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2026-2031)
4.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2020-2031)
4.3 Global Nuclear Medicine Radioisotopes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nuclear Medicine Radioisotopes Sales by Application (2020-2031)
5.1.1 Global Nuclear Medicine Radioisotopes Sales by Application (2020-2025)
5.1.2 Global Nuclear Medicine Radioisotopes Sales by Application (2026-2031)
5.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2031)
5.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2020-2031)
5.2.1 Global Nuclear Medicine Radioisotopes Revenue by Application (2020-2025)
5.2.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2026-2031)
5.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2020-2031)
5.3 Global Nuclear Medicine Radioisotopes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agfa-Gevaert Group
6.1.1 Agfa-Gevaert Group Company Information
6.1.2 Agfa-Gevaert Group Description and Business Overview
6.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolio
6.1.5 Agfa-Gevaert Group Recent Developments/Updates
6.2 Braco
6.2.1 Braco Company Information
6.2.2 Braco Description and Business Overview
6.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Braco Nuclear Medicine Radioisotopes Product Portfolio
6.2.5 Braco Recent Developments/Updates
6.3 Cardiarc
6.3.1 Cardiarc Company Information
6.3.2 Cardiarc Description and Business Overview
6.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cardiarc Nuclear Medicine Radioisotopes Product Portfolio
6.3.5 Cardiarc Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Company Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 CMR Naviscan (Gamma Medica Inc.)
6.5.1 CMR Naviscan (Gamma Medica Inc.) Company Information
6.5.2 CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
6.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolio
6.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates
6.6 Curium
6.6.1 Curium Company Information
6.6.2 Curium Description and Business Overview
6.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Curium Nuclear Medicine Radioisotopes Product Portfolio
6.6.5 Curium Recent Developments/Updates
6.7 Digirad
6.7.1 Digirad Company Information
6.7.2 Digirad Description and Business Overview
6.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Digirad Nuclear Medicine Radioisotopes Product Portfolio
6.7.5 Digirad Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Company Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 Nordion (Canada)
6.9.1 Nordion (Canada) Company Information
6.9.2 Nordion (Canada) Description and Business Overview
6.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolio
6.9.5 Nordion (Canada) Recent Developments/Updates
6.10 NTP Radioisotopes SOC
6.10.1 NTP Radioisotopes SOC Company Information
6.10.2 NTP Radioisotopes SOC Description and Business Overview
6.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolio
6.10.5 NTP Radioisotopes SOC Recent Developments/Updates
6.11 Positron
6.11.1 Positron Company Information
6.11.2 Positron Description and Business Overview
6.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Positron Nuclear Medicine Radioisotopes Product Portfolio
6.11.5 Positron Recent Developments/Updates
6.12 Segami
6.12.1 Segami Company Information
6.12.2 Segami Description and Business Overview
6.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Segami Nuclear Medicine Radioisotopes Product Portfolio
6.12.5 Segami Recent Developments/Updates
6.13 Siemens Healthcare
6.13.1 Siemens Healthcare Company Information
6.13.2 Siemens Healthcare Description and Business Overview
6.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolio
6.13.5 Siemens Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
7.2 Nuclear Medicine Radioisotopes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medicine Radioisotopes Production Mode & Process Analysis
7.4 Nuclear Medicine Radioisotopes Sales and Marketing
7.4.1 Nuclear Medicine Radioisotopes Sales Channels
7.4.2 Nuclear Medicine Radioisotopes Distributors
7.5 Nuclear Medicine Radioisotopes Customer Analysis
8 Nuclear Medicine Radioisotopes Market Dynamics
8.1 Nuclear Medicine Radioisotopes Industry Trends
8.2 Nuclear Medicine Radioisotopes Market Drivers
8.3 Nuclear Medicine Radioisotopes Market Challenges
8.4 Nuclear Medicine Radioisotopes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
List of Tables
 Table 1. Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nuclear Medicine Radioisotopes Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nuclear Medicine Radioisotopes Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nuclear Medicine Radioisotopes Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nuclear Medicine Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Product Type & Application
 Table 12. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nuclear Medicine Radioisotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2025)
 Table 19. Global Nuclear Medicine Radioisotopes Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2026-2031)
 Table 21. Global Nuclear Medicine Radioisotopes Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2025)
 Table 23. Global Nuclear Medicine Radioisotopes Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2026-2031)
 Table 25. North America Nuclear Medicine Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nuclear Medicine Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nuclear Medicine Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nuclear Medicine Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nuclear Medicine Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nuclear Medicine Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nuclear Medicine Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nuclear Medicine Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nuclear Medicine Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nuclear Medicine Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2020-2025)
 Table 51. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2026-2031)
 Table 52. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2025)
 Table 53. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2026-2031)
 Table 54. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2020-2025)
 Table 57. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2026-2031)
 Table 58. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application (2020-2025)
 Table 61. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application (2026-2031)
 Table 62. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2025)
 Table 63. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2026-2031)
 Table 64. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2020-2025)
 Table 67. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2026-2031)
 Table 68. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2026-2031)
 Table 70. Agfa-Gevaert Group Company Information
 Table 71. Agfa-Gevaert Group Description and Business Overview
 Table 72. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product
 Table 74. Agfa-Gevaert Group Recent Developments/Updates
 Table 75. Braco Company Information
 Table 76. Braco Description and Business Overview
 Table 77. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Braco Nuclear Medicine Radioisotopes Product
 Table 79. Braco Recent Developments/Updates
 Table 80. Cardiarc Company Information
 Table 81. Cardiarc Description and Business Overview
 Table 82. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Cardiarc Nuclear Medicine Radioisotopes Product
 Table 84. Cardiarc Recent Developments/Updates
 Table 85. Cardinal Health Company Information
 Table 86. Cardinal Health Description and Business Overview
 Table 87. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Cardinal Health Nuclear Medicine Radioisotopes Product
 Table 89. Cardinal Health Recent Developments/Updates
 Table 90. CMR Naviscan (Gamma Medica Inc.) Company Information
 Table 91. CMR Naviscan (Gamma Medica Inc.) Description and Business Overview
 Table 92. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product
 Table 94. CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates
 Table 95. Curium Company Information
 Table 96. Curium Description and Business Overview
 Table 97. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Curium Nuclear Medicine Radioisotopes Product
 Table 99. Curium Recent Developments/Updates
 Table 100. Digirad Company Information
 Table 101. Digirad Description and Business Overview
 Table 102. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Digirad Nuclear Medicine Radioisotopes Product
 Table 104. Digirad Recent Developments/Updates
 Table 105. GE Healthcare Company Information
 Table 106. GE Healthcare Description and Business Overview
 Table 107. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. GE Healthcare Nuclear Medicine Radioisotopes Product
 Table 109. GE Healthcare Recent Developments/Updates
 Table 110. Nordion (Canada) Company Information
 Table 111. Nordion (Canada) Description and Business Overview
 Table 112. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Nordion (Canada) Nuclear Medicine Radioisotopes Product
 Table 114. Nordion (Canada) Recent Developments/Updates
 Table 115. NTP Radioisotopes SOC Company Information
 Table 116. NTP Radioisotopes SOC Description and Business Overview
 Table 117. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product
 Table 119. NTP Radioisotopes SOC Recent Developments/Updates
 Table 120. Positron Company Information
 Table 121. Positron Description and Business Overview
 Table 122. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Positron Nuclear Medicine Radioisotopes Product
 Table 124. Positron Recent Developments/Updates
 Table 125. Segami Company Information
 Table 126. Segami Description and Business Overview
 Table 127. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Segami Nuclear Medicine Radioisotopes Product
 Table 129. Segami Recent Developments/Updates
 Table 130. Siemens Healthcare Company Information
 Table 131. Siemens Healthcare Description and Business Overview
 Table 132. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Siemens Healthcare Nuclear Medicine Radioisotopes Product
 Table 134. Siemens Healthcare Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Nuclear Medicine Radioisotopes Distributors List
 Table 138. Nuclear Medicine Radioisotopes Customers List
 Table 139. Nuclear Medicine Radioisotopes Market Trends
 Table 140. Nuclear Medicine Radioisotopes Market Drivers
 Table 141. Nuclear Medicine Radioisotopes Market Challenges
 Table 142. Nuclear Medicine Radioisotopes Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nuclear Medicine Radioisotopes
 Figure 2. Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nuclear Medicine Radioisotopes Market Share by Type: 2024 & 2031
 Figure 4. Thallium-201 (Tl-201) Product Picture
 Figure 5. Iodine (I-123) Product Picture
 Figure 6. Fluorine-18 Product Picture
 Figure 7. Rubidium-82 (Rb-82) Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Nuclear Medicine Radioisotopes Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Nuclear Medicine Radioisotopes Market Share by Application: 2024 & 2031
 Figure 11. Tumor
 Figure 12. Heart Disease
 Figure 13. Lymphoma
 Figure 14. Thyroid Gland
 Figure 15. Other
 Figure 16. Global Nuclear Medicine Radioisotopes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Nuclear Medicine Radioisotopes Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Nuclear Medicine Radioisotopes Sales (2020-2031) & (K Units)
 Figure 19. Global Nuclear Medicine Radioisotopes Average Price (USD/Unit) & (2020-2031)
 Figure 20. Nuclear Medicine Radioisotopes Report Years Considered
 Figure 21. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2024
 Figure 22. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players: Market Share by Revenue in Nuclear Medicine Radioisotopes in 2024
 Figure 24. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Nuclear Medicine Radioisotopes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Nuclear Medicine Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 27. North America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 31. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2031)
 Figure 39. China Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Nuclear Medicine Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Nuclear Medicine Radioisotopes Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Nuclear Medicine Radioisotopes by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Nuclear Medicine Radioisotopes by Type (2020-2031)
 Figure 61. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Nuclear Medicine Radioisotopes by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Nuclear Medicine Radioisotopes by Application (2020-2031)
 Figure 64. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2020-2031)
 Figure 65. Nuclear Medicine Radioisotopes Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Radioisotopes in Medicine Market Research Report 2025
Global Nuclear Medicine System Market Insights Forecast to 2030
Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024
Global Therapeutic Radioisotopes Market Insights Forecast to 2030
Global Medical Radioisotopes Market Research Report 2025
Global Radiopharmaceutical for Nuclear Medicine Market Research Report 2024
Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030
Global Prostate Cancer Nuclear Medicine Diagnostics Market Insights Forecast to 2030
Global Nuclear Medicine Market Research Report 2025
Nuclear Medicine Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nuclear Medicine Isotopes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radioactive Therapeutic Drugs Market Research Report 2024
Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030
Global Medical Radioactive Isotopes Market Research Report 2025
Global Diagnostic Radioisotopes Market Insights Forecast to 2030
Nuclear Medicine Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030
Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025
Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024
Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions